Phenomycin (PHM), an antitumor antibiotic, was isolated from a culture of Streptoverticillium baldacci Ma564-Cl 1}. The inhibition of protein synthesis in tumor cells1} and the inhibition of initiation of globin synthesis in a rabbit cell-free system2) are the biological features of PHM. It also had a significant inhibitory effect on the growth of Ehlrich carcinoma, sarcoma 180, and adenocarcinoma 755 in mice3). In contrast, there was no inhibition against Gram-positive and Gram-negative bacterial growth up to lOO /ig/ml^.
Wehave shown previously that PHMconsists of 89 amino acid residues (MW9,524) and has no disulfide bridges4). The amino acid sequence was identical to that deduced from the nucleotide sequence of the PHMgene isolated from the strain Ma564-Cl5). However, since production level ofPHM by the strain Ma564-Cl remains at a low level, we tried to improve PHMproduction by a genetically engineering; Escherichia coli transformed with a plasmid containing the synthetic PHMgene. Expectedly, a markedly improved PHMproduction was achieved and the biological activity ofrecombinant PHM was comparable to that of natural PHMin vivo.
Materials and Methods
Organisms and Plasmids Escherichia coli JM 109 and a plasmid, pUC18, were purchased from Pharmacia (Uppsala, Sweden). Plasmid pMTSHVl,which had been constructed as a Hirudin variant 1 (HV1) expression vector6) was provided by S. 
Plasmid Construction
The scheme of construction of expression vector PMTSHXPM is outlined in Fig. 1 . In order to construct 
Cultivation of E. coli and Purification of the Fusion Protein
One hundred ml of a seed culture which was incubated at 30°C for 16 hours in 2xTYmediumconsisting of Bactotryptone 1.6%, yeast extract 1% and NaCl 0.5% (pH 7.0) was inoculated into 2.5 liters of 2 x TY medium supplemented with 2% glycerol in a 5-liter jar fermenter and cultivated at 37°C for 20 hours. The expression level of the fusion protein was monitored by SDS-PAGE. Cells were harvested by centrifugation, suspended in sterile water (1 mg cells/ml) and sonicated for 3 minutes using a Sonifier 250 (Branson, Connecticut, U.S.A. Amino Acid Analysis Recombinant PHM(10fig) was hydrolyzed with 6n HC1 containing 1 %phenol in a Millipore Picotag system at 110°C for 24 hours. Each hydrolysate was dried and analyzed on a Beckmanmodel 7300 amino acid analyzer.
In Vivo Antitumor Activity
The male BALB/c mice weighing 21~25 g (Japan Clea, Tokyo, Japan) were implanted intraperitoneally with 2x 106 Meth A cells on day 0, and randomly divided into three groups; control (n= 13), natural PHM(n=6), and recombinant PHM(n= 6). These mice were treated once daily for 7 consecutive days by intraperitoneal administration of the respective test sample or saline (control) starting at 24 hours after the implantation. Survival periods were observed, and the antitumor activity was evaluated in terms of the increase in life span. Fig. 2A; lanes 1, 2) . The apparent molecular weight corresponded to that calculated from the amino acid sequence. This overexpressed protein was not found in the periplasmic fraction (Fig. 2B) , but in the soluble fraction (Fig. 2C ).
The 14,000 dalton protein was purified by ultra filtra- Cleavage of the Fusion Protein and Purification of Recombinant PHM Recombinant PHMwas released from the fusion protein by cleavage with factor Xa in a very low yield (Fig. 3A) . Trypsin, unlike factor Xa, released recom- One hundred fA of the purified fusion protein (0.4/ig//zl) was incubated with bovine pancreas l-1-tosylamide-2-phenylethyl chloromethyl ketone-treated Type XIII trypsin at an enzyme substrate ratio of 1:100 (w/w).
At each time point, 5 /il of the reaction mixture was taken out, mixed with 5/il of0.2m Tris-HCl (pH 8.0), 1% SDS, 10% glycerol and 10% 2-mercaptoethanol and analyzed by SDS-PAGE. binant PHMefficiently, with cleavage being completed within 4 hours. The fusion protein was mainly cleaved at a single, specific site by trypsin, even though the protein contained 5 arginine and 12 lysine residues (Fig. 3B) . The reaction mixture of trypsin cleavage was directly subjected to reverse-phase HPLC. Recombinant PHM and natural PHMwere eluted at the identical retention time in the same HPLCsystem. The recovery yield of recombinant PHM from the fusion protein was approximately 55% by weight, that is 80% yield on the molar basis.
The purity of recovered recombinant PHMwas more than 95% when assessed by analytical HPLC (Fig. 4) . Furthermore the amino acid composition ofrecombinant Purified recombinant PHMwas applied onto a Tosoh TSK Gel ODS 120T column (0.46 x 15cm) and was eluted with a linear gradient of acetonitrile concentrations from 20 to 50% in 0.1% TFA over 30 minutes at a flow rate of 1 ml/minute. Numbers in parentheses are taken from the reported amino acid sequence of natural PHM.
ND: Not detected.
PHMwas in good agreement with that calculated on the basis of the amino acid sequence of PHM (Table 1) .
Taken all together, the data indicated that the trypsincleavage site was confined to the carboxyl side ofarginine residue of the factor Xa recognition sequence. Contamination by trypsin was checked with a fluorogenic peptide substrate8), and no activity of trypsin was found in recombinant PHMpreparation.
The trypsinization of the fusion protein purified by ultra filtration and ion-exchange chromatography gave efficiently recombinant PHMat a final yield of 50 mg/liter of culture, which was six times higher than that obtained 
Discussion
To our knowledge, there has been no literature reporting an enhanced production of a polypeptide antibiotic by a genetically engineered E. coli. The productivity of this new production system is six times higher than that from the natural microorganism. This high level production of biologically active recombinant PHMwithout c^ny folding procedures can be attributed to the nature ofPHMthat consists of only L-amino acid residues and has no disulfide bridges. In this expression system, a native protein is released from its fusion protein by treatment with trypsin or factor Xa. Our first attempt to cleave the fusion protein with factor Xa9'10) resulted in a poor recovery. Wingender et al. reported that a cro-^-galactosidase-hPTH fusion protein containing the factor Xa recognition site was not cleaved by factor Xa, suggesting that the cleavage site in this protein was blocked from the enzyme11}. However, after the fusion protein was denatured with guanidine hydrochloride to render the factor Xa site accessible to the enzyme, the efficiency of factor Xa cleavage remained unimproved (Fig. 3A) . Therefore, it seems likely that the Gly-Ser-Arg domain is blocked from trypsin in this protein owing to its secondary or higher dimensional structures.
Due to the establishment of a high-level PHMexpression system, it became possible to obtain a large 85 amount of PHMfor the further biological studies. This expression system is also suitable for site-directed mutagenesis to study the effect of individual amino acid residues on the function ofPHMand offers a convenient method for the production of other polypeptide antibiotics resembling to PHM.
